Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Yannick Marc"'
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 140, Iss , Pp 111682- (2021)
In the brain, aminopeptidase A (APA) generates angiotensin III, one of the effector peptides of the brain renin-angiotensin system (RAS), exerting tonic stimulatory control over blood pressure (BP) in hypertensive rats. Oral administration of firibas
Externí odkaz:
https://doaj.org/article/709322a76624434daf83fef10b58187e
Autor:
Nannan Xiao, Peter Bock, Sebastian J. Antreich, Yannick Marc Staedler, Jürg Schönenberger, Notburga Gierlinger
Publikováno v:
Frontiers in Plant Science, Vol 11 (2020)
The walnut shell is a hard and protective layer that provides an essential barrier between the seed and its environment. The shell is based on only one unit cell type: the polylobate sclerenchyma cell. For a better understanding of the interlocked wa
Externí odkaz:
https://doaj.org/article/7618e04f3e884e3db4cbef9aab4399b6
Publikováno v:
Journal of Cardiovascular Pharmacology. 73:82-91
Aims Inhibition of brain angiotensin III by central infusion of aminopeptidase A (APA) inhibitor firibastat (RB150) inhibits sympathetic hyperactivity and heart failure in rats after myocardial infarction (MI). This study evaluated effectiveness of s
Autor:
Adrien Flahault, Romain Gerbier, Yannick Marc, Catherine Llorens-Cortes, Nadia De Mota, Reda Hmazzou
Publikováno v:
Clinical science (London, England : 1979). 135(6)
In the brain, aminopeptidase A (APA), a membrane-bound zinc metalloprotease, generates angiotensin III from angiotensin II. Brain angiotensin III exerts a tonic stimulatory effect on the control of blood pressure (BP) in hypertensive rats and increas
Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure
Autor:
Solène Emmanuelle Boitard, Fabrice Balavoine, Yannick Marc, Michel Azizi, Catherine Llorens-Cortes
Publikováno v:
Canadian Journal of Cardiology
Canadian Journal of Cardiology, Elsevier, 2020, 36 (5), pp.721-731. ⟨10.1016/j.cjca.2020.03.005⟩
Canadian Journal of Cardiology, Elsevier, 2020, 36 (5), pp.721-731. ⟨10.1016/j.cjca.2020.03.005⟩
The pathophysiology of heart failure (HF) and hypertension are thought to involve brain renin-angiotensin system (RAS) hyperactivity. Angiotensin III, a key effector peptide in the brain RAS, provides tonic stimulatory control over blood pressure (BP
Publikováno v:
Journal of Hypertension. 36:641-650
Background and objective Hyperactivity of the brain renin-angiotensin (Ang) system has been implicated in the development and maintenance of hypertension. AngIII, one of the main effector peptides of the brain renin-Ang system, exerts a tonic stimula
Autor:
Mathilde Keck, Bernard P. Roques, Fabrice Balavoine, Reda Hmazzou, Catherine Llorens-Cortes, Solène Emmanuelle Boitard, Yannick Marc
Publikováno v:
Journal of Hypertension. 39:e351-e352
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mathilde Keck, Fabrice Balavoine, N Mougenot, S Boitard-Joanne, Onnik Agbulut, Yannick Marc, Catherine Llorens-Cortes
Publikováno v:
European Heart Journal. 40
Introduction Brain renin-angiotensin system (RAS) hyperactivity has been implicated in sympathetic hyperactivity and progressive left ventricular (LV) dysfunction after myocardial infarction (MI). Brain angiotensin III, generated by aminopeptidase A